Abstract:Open-set recognition generalizes a classification task by classifying test samples as one of the known classes from training or "unknown." As novel cancer drug cocktails with improved treatment are continually discovered, predicting cancer treatments can naturally be formulated in terms of an open-set recognition problem. Drawbacks, due to modeling unknown samples during training, arise from straightforward implementations of prior work in healthcare open-set learning. Accordingly, we reframe the problem methodology and apply a recent existing Gaussian mixture variational autoencoder model, which achieves state-of-the-art results for image datasets, to breast cancer patient data. Not only do we obtain more accurate and robust classification results, with a 24.5% average F1 increase compared to a recent method, but we also reexamine open-set recognition in terms of deployability to a clinical setting.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: in breast cancer treatment, how to predict the effectiveness of new drug combination therapies for patients through open - set recognition. Specifically, researchers hope to develop a method that can not only classify known drug combination therapies, but also identify those "new" or "unknown" drug combinations that do not belong to known categories, and can accurately determine which patients may benefit from these new drug combinations. ### Problem Background Traditional classification tasks are usually closed - set, that is, the categories in the training and testing stages are the same. However, in the medical field, especially in cancer treatment, new drug combinations are constantly being discovered, resulting in the possibility of categories that have not been seen during training appearing in the testing stage. Therefore, it is very necessary to model the prediction problem of cancer treatment as an open - set recognition problem. This can better cope with the emergence of new drug combinations and improve robustness and accuracy in clinical applications. ### Research Objectives 1. **Classify Known Drug Combinations**: Classify patients into known drug combination categories according to their medical and demographic characteristics. 2. **Identify Unknown Drug Combinations**: For patients who are significantly different from those with known drug combinations, classify them into the "new" or "unknown" category, indicating that there may be new drug combinations more suitable for them. 3. **Improve the Accuracy and Robustness of the Model**: Compared with existing methods, the proposed method can maintain higher accuracy and robustness when dealing with an increasing number of unknown drug combinations. ### Solutions Researchers adopted a deep - learning model based on Gaussian Mixture Variational Auto - Encoder (GMVAE). GMVAE can not only perform classification, but also capture the structural information of data through reconstruction learning. In addition, GMVAE improves the flexibility and adaptability of the model by introducing an "uncertainty" threshold to distinguish between known and unknown categories. ### Main Contributions 1. **Performance Improvement**: Compared with the existing state - of - the - art deep open - set classifiers, GMVAE has a significant improvement in both accuracy and robustness, with an average increase of 24.5% in the F1 score. 2. **Feasibility of Practical Deployment**: GMVAE combined with the "uncertainty" threshold selection method provides an intuitive and practical single - threshold selection strategy, which is suitable for decision - support systems in the actual clinical environment. Through this method, researchers hope to help doctors more effectively identify cancer patients who may benefit from new drug combinations, thereby promoting the development of personalized medicine.

Open-Set Recognition of Breast Cancer Treatments

Multi-label Recognition of Cancer-Related Lesions with Clinical Priors on White-Light Endoscopy

Rethinking Breast Cancer Diagnosis through Deep Learning Based Image Recognition

An Ensemble Learning Approach for Cancer Drug Prediction

Semi-supervised and Class-imbalanced Open Set Medical Image Recognition

Learning Large Margin Sparse Embeddings for Open Set Medical Diagnosis

Breast Cancer Identification Using Machine Learning

Evaluation of Various Open-Set Medical Imaging Tasks with Deep Neural Networks

Informed Decision-Making through Advancements in Open Set Recognition and Unknown Sample Detection

Conditional Gaussian Distribution Learning for Open Set Recognition

Lesion-Aware Open Set Medical Image Recognition with Domain Shift.

CandidateDrug4Cancer: An Open Molecular Graph Learning Benchmark on Drug Discovery for Cancer

Interpretability methods of machine learning algorithms with applications in breast cancer diagnosis

A Multi-Institutional Open-Source Benchmark Dataset for Breast Cancer Clinical Decision Support using Synthetic Correlated Diffusion Imaging Data

Open Set Recognition for Random Forest

Identification of Differentially Expressed Genes Between Original Breast Cancer and Xenograft Using Machine Learning Algorithms

Augmented data strategies for enhanced computer vision performance in breast cancer diagnosis

Cascading Unknown Detection with Known Classification for Open Set Recognition

Classifying breast cancer using transfer learning models based on histopathological images

A unified computational model for revealing and predicting subtle subtypes of cancers

Learning Eligibility in Cancer Clinical Trials using Deep Neural Networks